Sign Up Now to Download a Free Research Report on AEGR
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals shares spiked 14.06 percent on volume of 2.18 million shares traded Wednesday to close at $69.28. JPMorgan currently has an “overweight” rating on the company and has recently raised its price target to $69.00 from $48.00. Shares of Aegerion Pharmaceuticals have gained over 170 percent year-to-date.
Going forward ... (see research report)
Subscribe to News Feeds